Showing 1-10 of about 63 articles.
Global Blood Therapeutics, Inc.
Data Supporting the Potential of Voxelotor as a Disease-Modifying Treatment for Sickle Cell Disease(SCD) Published in The New England Journal of Medicine and to be Presented During...
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that five nonprofit organizations have been awarded more than...
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., June 07, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on June 1, 2019, the compensation committee of GBT’s board of...
Global Blood Therapeutics, Inc.
Phase 3 HOPE Study 24-Week Efficacy Results from Full Patient Cohort to be Presented During Presidential Symposium New Drug Application (NDA) Submission Planned for Voxelotor to Include HOPE Study...
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today reported recent business progress and financial results for the first quarter...
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 06, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on May 1, 2019, the compensation committee of GBT’s board of...
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on April 1, 2019, the compensation committee of GBT’s board...
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the H.C. Wainwright Global Life Sciences...
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on March 1, 2019, the compensation committee of GBT’s board...
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the Cowen and Company 39th Annual Health...
Showing 1-10 of about 63 articles.
